Case reports

Case Reports: Beauty Bay and Dotcom Retail v Benefit Cosmetics [2019] EWHC 1150 (Ch) The English High Court has recently given judgment in the case Beauty Bay and Dotcom Retail v Benefit Cosmetics [2019] EWHC 1150 (Ch), which serves as a useful reminder of how the courts should assess the likelihood of confusion in infringement cases based on the circumstances in which the allegedly infringing goods are sold.
July 2019
Plausibility Put to the Test Eli Lilly and Company (and 7 other Lilly companies) v Genentech, Inc. This decision from the UK High Court relates to...
May 2019
Inventiveness for expandable hose proves too much of a stretch E Mishan & Sons (trading as Emson) v (1) Hozelock Limited, (2) Blue Gentian LLC, (3) Telebrands Corp This recent...
May 2019
SAKURA SAKURA! – who is the average consumer? Decision of the Appointed Person (Professor Ruth Annand) 20th March 2019
April 2019
Supreme Court Rules Dosage Regime Patent Obvious This recent Supreme Court decision relates to obviousness of a dosage regime patent. The case raised two principal...
April 2019
Case report: Trump International Ltd v DTTM Operations LLC [2019] EWHC 769 (Ch) Trump International Limited is a UK company incorporated in October 2016. Though you may expect otherwise from the name...
April 2019
CJEU provides guidance on SPCs for combination products On the 25 July 2018, the Court of Justice of the European Union (the CJEU) handed down its judgement in Teva v Gilead (...
August 2018
The latest CJEU referral relating to SPCs (1) Sandoz Limited, (2) Hexal AG v (1) G.D. Searle LLC, (2) Janssen Sciences Ireland UC This decision from the UK Court...
March 2018
Refusal of Transfer of Cases Between IPEC and High Court 77M Limited v (1) Ordnance Survey Limited and (2) The Controller of Her Majesty’s Stationery Office This recent case...
September 2017
The Supreme Court on Using Prosecution History to Interpret Claims We reported recently that the UK Supreme Court has issued a judgment in Eli Lilly v Actavis UK Limited . The judgment is about the infringement by Actavis of Eli Lilly’s patent claiming an anti-cancer drug containing pemetrexed disodium and vitamin B12.
August 2017

Pages